A recently published study by FMI expects the global Intratumoral Cancer Therapies market to garner a market value of US$ 212.96 Billion in 2023 and is expected to accumulate a market value of US$ 552.36 Billion by registering a CAGR of10% in the forecast period 2023-2033. Growth of the Intratumoral Cancer Therapies market can be …
Category Archives: Healthcare Trends
North America to Procure 40% Market Share for IgA Nephropathy Market in the Forecast Period 2023 to 3033 | FMI Study
During the forecast period 2023-2033, the IgA nephropathy market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for IgA nephropathy is expected to rise up to a market valuation of US$ 85 Billion. Key factors such as high prevalence of kidney …
Combined Sales of Anti-biofilm Wound Dressing is expected to reach US$ 1939.45 million by 2033 | Development in Telehealth Platforms Surges the Sales of Anti-biofilm Wound Dressing.
The net worth of the market share of the anti-biofilm wound dressing is predicted to reach from US$ 782.60 million in 2023 to over US$ 1939.45 million by 2033, recording a CAGR of 9.5% between 2023 and 2033. Incidence rates for chronic and acute wounds are expected to increase which is, driving demand for anti-biofilm wound dressings. Besides antimicrobial …
Personalized Medicine Market through Personalized Nutrition & Wellness to Surge at over 6% CAGR from 2022 to 2033
The global Personalized Medicine Market is valued at US$ 315.7 Billion in 2022 and is expected to reach US$ 690.9 Billion by 2033, expanding at a CAGR of 7.8% between 2022 and 2033. In recent years, a significant focus is on how to employ advanced analytics, customized drugs, patient data, and other tools to better …
Demand for Monoclonal Antibodies and RNA Vaccines to Drive Cholesterol API Market Across Europe | Germany to Register 4.9% CAGR States FMI
The global Cholesterol Active Pharmaceutical Ingredient (API) Market is projected to be valued at US$ 269.0 Million by the end of 2022, and to grow at a CAGR of 4.7% between 2022 and 2032. By 2032, the global market for cholesterol API is expected to be worth US$ 426.9 Million. Germany is predicted to remain …
Popularity of Biopsy Devices in Minimally Invasive Procedures to Create Lucrative Opportunities for European Manufacturers | Introduction of Reimbursement Policies to Act as Catalyst
According to Future Market Insights (FMI), the U.K. Biopsy Device Market is poised to expand at a CAGR of 3.9% during the assessment period, reaching a valuation of US$ 159 Million by 2033. Germany’s biopsy device market is likely to accelerate at a CAGR of 4.1% during the anticipated timeframe with overall sales anticipated to …
Europe Balloon Catheter Market to Witness Billion $ Opportunity Amid Rising Prevalence of Peripheral Artery Disease | United Kingdom to Hold Lion’s Share, Exceeding US$ 273.4 Million by 2033
The United Kingdom Balloon Catheter Market is expected to reach a total of US$ 273.4 million by 2033, and likely to expand at a steady CAGR of 4.8% from 2023 to 2033. Germany balloon catheter market is also set to expand at a steady 4.7% CAGR, and the sales of balloon catheter is anticipated to …
Hematopoietic Stem Cell Transplantation to Hog Limelight in Europe from 2023 to 2033 | FMI Foresees a Healthy 7.6% CAGR
As per the report published by Future Market Insights (FMI), the Hematopoietic Stem Cell Transplantation (HSCT) market in Europe is projected to accelerate at a CAGR of 7.6% from 2023 to 2033. Leukemia and lymphoproliferative disorders are among the most common types of medical conditions in Europe and reported cases have been steadily rising in …
Korea’s Development of Petconomy is Changing the Way Companion Animal Specialty Drug Manufacturers Operate
South Koreans are expected to spend US$ 3 billion on their pets in 2020 and more than US$ 3.5 billion in 2021, resulting in an increase in pet-related businesses in Korea. According to the Korea Rural Economic Institute, this figure is expected to reach US$ 5 billion by 2027, creating opportunities for Korea’s companion animal specialty …
Treatment-Resistant Depression Treatment Market is expected to reach US$ 4 Billion by 2033
In 2023, the global Treatment-Resistant Depression Treatment Market is anticipated to be worth US$ 1.69 billion. Because of the rising frequency of depression and anxiety disorders in adults, as well as the ageing population, the global demand for treatment-resistant depression treatment is expected to expand at a CAGR of 9.0% between 2023 and 2033, totaling …